Previous close | 0.0100 |
Open | 0.0100 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 0.0100 - 0.0100 |
52-week range | 0.0010 - 0.0750 |
Volume | |
Avg. volume | 22,937 |
Market cap | 270,192 |
Beta (5Y monthly) | 2.69 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.1000 |
Earnings date | 13 May 2024 - 17 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor Notice on SEDAR+ together w
TORONTO, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: MEDVF; FRA:4NC) is pleased to announce that it has entered into a master services agreement dated December 29, 2023, with Engineer.ai Corp. (dba Builder.ai) (“Builder”) to assist in the development of its telehealth platform. Pursuant to the agreement, Builder will develop robust features of the platform, including but not limited to, provider and patient interfacing, telehealth video confer
TORONTO, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from McGovern Hurley LLP (“McGovern”) to MNP LLP (“MNP”), effective November 9, 2023. At the request of the Company, McGovern has resigned as of the effective date of November 9, 2023. MNP has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor No